Mersana Therapeutics Price to Sales Ratio 2016-2022 | MRSN
Historical PS ratio values for Mersana Therapeutics (MRSN) over the last 10 years. The current P/S ratio for Mersana Therapeutics as of May 25, 2022 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Mersana Therapeutics P/S Ratio Historical Data |
| Date |
Stock Price |
TTM Sales per Share |
Price to Sales Ratio |
| 2022-05-25 |
3.21 |
|
123.82 |
| 2022-03-31 |
3.99 |
$0.03 |
153.90 |
| 2021-12-31 |
6.22 |
$0.00 |
0.00 |
| 2021-09-30 |
9.43 |
$0.00 |
0.00 |
| 2021-06-30 |
13.58 |
$0.00 |
0.00 |
| 2021-03-31 |
16.18 |
$0.01 |
1190.92 |
| 2020-12-31 |
26.61 |
$0.01 |
1948.60 |
| 2020-09-30 |
18.62 |
$0.01 |
1287.78 |
| 2020-06-30 |
23.40 |
$0.03 |
732.56 |
| 2020-03-31 |
5.83 |
$0.02 |
252.67 |
| 2019-12-31 |
5.73 |
$1.33 |
4.32 |
| 2019-09-30 |
1.58 |
$1.38 |
1.15 |
| 2019-06-30 |
4.05 |
$1.45 |
2.79 |
| 2019-03-31 |
5.26 |
$1.63 |
3.22 |
| 2018-12-31 |
4.08 |
$0.46 |
8.85 |
| 2018-09-30 |
10.00 |
$0.68 |
14.69 |
| 2018-06-30 |
17.86 |
$0.87 |
20.53 |
| 2018-03-31 |
15.77 |
$3.33 |
4.74 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.316B |
$0.000B |
|
Mersana Therapeutics, Inc. is a biotechnology company. It focused on discovering and developing a pipeline of antibody drug conjugates. The company's product candidates include XMT-1522 and XMT-1536 which are in clinical stage. Mersana Therapeutics, Inc. is based in CAMBRIDGE, United States.
|
